We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Robotic Biopsy System Diagnoses Peripheral Lung Cancer

By HospiMedica International staff writers
Posted on 06 Mar 2019
A minimally invasive lung cancer biopsy system snakes its way through the airways to reach nodules in the peripheral lung.

The Intuitive Surgical (Sunnyvale, CA, USA) Ion endoluminal system is based on an ultra-thin articulating robotic catheter that can move 180 degrees in all directions. With an outer diameter of just 3.5 mm and a working channel of 2 mm, physicians are able to navigate through small and tortuous airways to reach nodules in any of the 18 airway segments within the lung. Ion is designed to integrate into existing lung nodule biopsy workflows, as well as into existing imaging technologies, including fluoroscopy, radial-endobronchial ultrasound, and cone-beam CT.

Image: The Ion endoluminal system lung biopsy system (Photo courtesy of Intuitive Surgical).
Image: The Ion endoluminal system lung biopsy system (Photo courtesy of Intuitive Surgical).

The minimally invasive system also employs fiber-optic sensor technology, which details the precise shape and length of the catheter for the surgeon throughout the procedure. Once a target nodule is reached, the catheter locks in place to provide the stability needed for precise placement of biopsy tools. The Flexision flexible biopsy needle can then collect tissue samples within the peripheral lung. The catheter’s working channel can also accommodate additional biopsy tools, such as forceps or cytology brushes, if necessary.

“Early lung cancer diagnosis can save lives. Intuitive’s advanced, robotic-assisted, minimally invasive Ion system helps address a challenging aspect of lung biopsy by enabling physicians to obtain tissue samples from deep within the lung,” said Gary Guthart, CEO of Intuitive Surgical. “Lung cancer is clearly a global health challenge that requires new modalities of care. The Ion system represents Intuitive’s continued commitment to innovating for minimally invasive care, and extends our focus beyond surgery.”

Lung cancer is a malignant tumor characterized by uncontrolled cell growth in tissues of the lung. If left untreated, it can form metastases in nearby tissues or other parts of the body. Primary lung cancers are carcinomas derived from epithelial cells, with the main types being small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). As pulmonary nodules are found in up to 25% of patients undergoing a chest CT, the question of whether or not to perform a biopsy is becoming increasingly common.


Gold Member
12-Channel ECG
CM1200B
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Forceps
BiClamp LAP

Latest Surgical Techniques News

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Soft, Flexible, Battery-Free Implant Continuously Monitors Bladder Function